Table I.
Clinical characteristics of patients with lung cancer included in the present study prior to CIK treatment (n=57).
| Characteristic | Total (n=57) | CIK (n=17) | Che-Sur (n=21) | Che-Rad (n=19) |
|---|---|---|---|---|
| Patient | ||||
| Gender (M/F) | 40/17 | 13/4 | 13/8 | 14/5 |
| Age, years | 63.5±11.3 | 64.6±12.9 | 63.8±12.2 | 62.1±8.0 |
| Tumor stage | ||||
| II | 7 | 3 | 3 | 1 |
| III | 7 | 2 | 1 | 4 |
| IV | 43 | 12 | 17 | 14 |
| Histopathological type | ||||
| Adenocarcinoma | 17 | 6 | 4 | 5 |
| Squamous cell carcinoma | 10 | 1 | 8 | 3 |
| Small cell lung cancer | 11 | 2 | 3 | 7 |
| Adenosquamous carcinoma | 5 | 1 | 3 | 1 |
| Not determined | 14 | 7 | 3 | 3 |
CIK, cytokine-induced killer; Che, chemotherapy; Sur, surgery; Rad, radiotherapy; M, male; F, female.